Literature DB >> 15508935

The clinical presentation of lysosomal storage disorders.

James E Wraith1.   

Abstract

Lysosomal storage disorders (LSDs) are present from conception and produce a clinical phenotype that evolves with time. The introduction of new therapies has made early diagnosis a priority. Clues to the clinical diagnosis of a LSD can be found in the tempo of the illness especially if the central nervous system is involved. Loss of a previously acquired skill (regression) is very characteristic of this group of disorders. Other clinical clues can include a dysmorphic appearance or the presence of characteristic skeletal involvement (dysostosis multiplex), but in some disorders such as Pompe disease or Krabbe disease, these do not occur. The approach to diagnosis has to involve "screening" as there can be considerable overlap in clinical presentation (e.g. Gaucher disease and Niemann-Pick B). Both urine and blood testing are necessary and the majority of diagnoses can now be confirmed at a molecular level. Prenatal diagnosis is possible for all.

Entities:  

Mesh:

Year:  2004        PMID: 15508935

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  9 in total

Review 1.  Clinical neurogenetics: neuropathic lysosomal storage disorders.

Authors:  Gregory M Pastores; Gustavo H B Maegawa
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

2.  Effect of temperature on lysosomal enzyme activity during preparation and storage of dried blood spots.

Authors:  Manjunath Supriya; Tanima De; Rita Christopher
Journal:  J Clin Lab Anal       Date:  2017-03-27       Impact factor: 2.352

3.  Newborn screening for lysosomal diseases: current status and potential interface with population medical genetics in Latin America.

Authors:  Roberto Giugliani
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

4.  Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.

Authors:  David A Stevenson; Kyle Rudser; Alicia Kunin-Batson; Ellen B Fung; David Viskochil; Elsa Shapiro; Paul J Orchard; Chester B Whitley; Lynda E Polgreen
Journal:  J Pediatr Rehabil Med       Date:  2014

Review 5.  Radiological and clinical characterization of the lysosomal storage disorders: non-lipid disorders.

Authors:  E I Parker; M Xing; A Moreno-De-Luca; E Harmouche; M R Terk
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

Review 6.  Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases.

Authors:  James C Dodge
Journal:  Front Mol Neurosci       Date:  2017-11-03       Impact factor: 5.639

7.  Lysosomal Storage Disorders: Clinical, Biochemical and molecular profile from Rare disease centre, India.

Authors:  Manisha Goyal; Ashok Gupta
Journal:  Ann Indian Acad Neurol       Date:  2021-03-27       Impact factor: 1.383

Review 8.  Bone Biomarkers in Mucopolysaccharidoses.

Authors:  Akari Nakamura-Utsunomiya
Journal:  Int J Mol Sci       Date:  2021-11-23       Impact factor: 5.923

Review 9.  Recent Advances in RNA Therapy and Its Carriers to Treat the Single-Gene Neurological Disorders.

Authors:  Ming-Jen Lee; Inyoul Lee; Kai Wang
Journal:  Biomedicines       Date:  2022-01-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.